NCT00408902 2017-11-22
Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
4 trialsNCT00379080 2017-04-07
Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00667394 2015-11-05
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00390468 2014-05-28
Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases
National Cancer Institute (NCI)
Phase 2 Completed